Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nidhi S. Kansara"'
Autor:
Svetlana E. Semina, Luis H. Alejo, Shivani Chopra, Nidhi S. Kansara, Irida Kastrati, Carol A. Sartorius, Jonna Frasor
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-19 (2022)
Abstract Background Up to 40% of patients with estrogen receptor-positive (ER+) breast cancer experience relapse. This can be attributed to breast cancer stem cells (BCSCs), which are known to be involved in therapy resistance, relapse, and metastasi
Externí odkaz:
https://doaj.org/article/f3161eb0e67345e59d5aa35198f1b009
Autor:
Svetlana E. Semina, Purab Pal, Nidhi S. Kansara, Rosemary J. Huggins, Elaine T. Alarid, Geoffrey L. Greene, Jonna Frasor
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background While estrogen receptor (ER) positive breast tumors generally respond well to endocrine therapy (ET), up to 40% of patients will experience relapse, either while on endocrine therapy or after ET is completed. We previously demonst
Externí odkaz:
https://doaj.org/article/5a725f4f8f5b4268a101733cf55d706a
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2848
Most metastatic breast cancers arise from estrogen receptor α (ER)-positive disease, and yet the role of ER in promoting metastasis is unclear. Here, we used an ER+ breast cancer cell line that is highly invasive in an ER- and IKKβ-dependent manner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81621ef860fca22491f67b346bd72e00
https://pubmed.ncbi.nlm.nih.gov/35740514
https://pubmed.ncbi.nlm.nih.gov/35740514